Background
Primary open angle glaucoma (POAG) is a progressive eye disease that leads to blindness due to the irreversible loss of retinal ganglion cells and degeneration of the optic nerve (ON). As of yet, there is no cure for glaucoma. Although available therapies delay disease progression, they offer incomplete protection. Elevated intraocular pressure (IOP) is an important risk factor for POAG. However, the exact molecular mechanisms that trigger increased IOP and glaucomatous optic neuropathy remain incompletely understood. While a few spontaneous murine models of glaucoma exist, none are models of POAG, the most prevalent form of glaucoma. Impaired nitric oxide (NO) signaling has been implicated in the development of glaucoma. To further test the hypothesis that impaired NO/cGMP signaling contributes to the pathogenesis of POAG, we tested whether mice lacking the α 1 subunit of the NO receptor soluble guanylate cyclase (sGCα 1 -/-mice) develop POAG.
Materials and methods
IOP was measured serially using a TonoLab-Tonometer in age-matched female wild-type (WT) and sGCα 1 -/-mice. Iridocorneal angle and trabecular meshwork in WT and sGCα1 -/-mice were examined by light and transmission electron microscopy. Aqueous humor turnover was assessed non-invasively using a fluorophotometric approach. Retinal nerve fiber layer (RNFL) thickness was measured via optical coherence tomography (SD-OCT, Bioptigen). Axons in ON crosssections, stained with paraphenylenediamine, were counted.
Results

IOP increased significantly with age in sGCα 1
-/-but not in WT mice. Morphological analysis revealed an open iridocorneal angle in eyes from sGCα 1 -/-mice with high IOP. Aqueous humor turnover rates were lower in sGCα 1 -/-than in WT mice, suggesting that increased outflow resistance underlies the elevated IOP. An agerelated thinning of the RNFL, consistent with glaucomatous injury, was observed in sGCα 1 -/-but not in WT mice. Similarly, axon counts were lower in ON isolated from sGCα 1 -/-than from WT mice.
Conclusion
sGCα 1 -deficiency is associated with increased IOP, decreased aqueous humor outflow, thinning of the RNFL and decreased axon counts in the ON. These findings support our hypothesis that sGCα 1 -/-mice develop POAG. Identifying a well-characterized signaling pathway (NO/cGMP signaling) as an important regulatory mechanism controlling outflow and IOP is expected to contribute significantly to our understanding of POAG pathogenesis and may inform the clinical development of existing cGMP-elevating therapeutic compounds for the treatment of elevated IOP and POAG. Moreover, the sGCα 1 -/-mouse model for POAG provides a novel and important tool to test other strategies for disease prevention and treatment of high IOP and POAG.
